Citation 5216

REN,YL: LANTVIT,DD: CARACHE DE BLANCO,EJ: KARDONO,LBS: RISWAN,S: CHAI,H: COTTRELL,CE: FARNSWORTH,NR: SWANSON,SM: DING,YQ: LI,XC: MARAIS,JPJ: FERREIRA,D: KINGHORN,AD:. (2010). PROTEASOME-INHIBITORY AND CYTOTOXIC CONSTITUENTS OF GARCINIA LAGERIFLORA: ABSOLUTE CONFIGURATION OF CAGED XANTHONES. 66(29)

Citation Details

Title	PROTEASOME-INHIBITORY AND CYTOTOXIC CONSTITUENTS OF GARCINIA LAGERIFLORA: ABSOLUTE CONFIGURATION OF CAGED XANTHONES
Authors	REN,YL: LANTVIT,DD: CARACHE DE BLANCO,EJ: KARDONO,LBS: RISWAN,S: CHAI,H: COTTRELL,CE: FARNSWORTH,NR: SWANSON,SM: DING,YQ: LI,XC: MARAIS,JPJ: FERREIRA,D: KINGHORN,AD:
Year	2010
Volume	66
Issue	29

Summary

Year: 2010

Journal: Unknown

Organisms and Their Experiments (1)

Garcinia lateriflora (CLUSIACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	VOUCHER SPECIMEN REPORTED FORUV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	LATERIFLAVANONE	None
2	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FOR	LATERIXANTHONE	None
3	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FOR	MOREOLLIC ACID,ISO: (-):	None
4	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	MOREOLLIC ACID,ISO: (-):	ACTIVE
5	PROTEASOME INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MOREOLLIC ACID,ISO: (-):	INACTIVE
6	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FOR	MOREOLLIC ACID,ISO: (-):GUADICHAUDIC ACID,ISO: (-):	None
7	PROTEASOME INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GUADICHAUDIC ACID,ISO: (-):	INACTIVE
8	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	GUADICHAUDIC ACID,ISO: (-):	ACTIVE
9	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	GAUDICHAUDIIC ACID E,ISO: (-):	None
10	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	GAUDICHAUDIIC ACID E,ISO: (-):	ACTIVE
11	PROTEASOME INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GAUDICHAUDIIC ACID E,ISO: (-):	INACTIVE
12	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FOR	MORELLIC ACID,11-12-DIHYRDO: 12-HYDROXY: (-):	None
13	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	MORELLIC ACID,11-12-DIHYRDO: 12-HYDROXY: (-):	ACTIVE
14	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FOR	GAUDICHAUDIIC ACID B,ISO:	None
15	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	GAUDICHAUDIIC ACID B,ISO:	INACTIVE
16	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	FUKUGETIN	None
17	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FUKUGETIN	INACTIVE
18	PROTEASOME INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FUKUGETIN	ACTIVE
19	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	TALBOTAFLAVONEFUKUGETIN	None
20	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	TALBOTAFLAVONE	INACTIVE
21	PROTEASOME INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TALBOTAFLAVONE	ACTIVE
22	PROTEASOME INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TALBOTAFLAVONE	None
23	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	RHUSFLAVANONE	None
24	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	STIGMASTA-5-13-DIENE 3-O-BETA-D-GLUCOSIDE	None
25	Not specified	UV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATACD SPECTRUM REPORTED FOR	MORELLIC ACID,(-):	None
26	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	MORELLIC ACID,(-):	INACTIVE
27	PROTEASOME INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MORELLIC ACID,(-):	INACTIVE
28	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	MORELLIC ACID,(-):	ACTIVE
29	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	URS-12-EN-28-OIC ACID,3-BETA-ACETOXY:	None

Citation 5216

Citation Details

Summary

Organisms and Their Experiments (1)

Garcinia lateriflora (CLUSIACEAE)

Show SPARQL Queries (1)

Query 1